Neuropeptides, apoptosis and ion changes in prostate cancer. Methods of study and recent developments

Histology and Histopathology

Volumn 19, Issue 3, 2004, Pages 951-961

  Vilches, José ^a   Salido, M ^a   Fernandez Segura E ^b   Roomans, G M ^c  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Ions; Neuropeptides; Prostate cancer; X ray microanalysis

Indexed keywords

ANDROGEN; BOMBESIN; CALCITONIN; ETOPOSIDE; HORMONE INHIBITOR; NEUROPEPTIDE;

APOPTOSIS; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL COMPOSITION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL PROTOCOL; CORRELATION ANALYSIS; CRYOPRESERVATION; DISEASE ACTIVITY; HUMAN; IN VITRO STUDY; METHODOLOGY; MONOLAYER CULTURE; NEUROSECRETORY CELL; PARACRINE SIGNALING; PROSTATE CARCINOMA; PROTEIN TARGETING; REVIEW; TISSUE FIXATION; X RAY MICROANALYSIS;

APOPTOSIS; CELL LINE, TUMOR; ELECTRON PROBE MICROANALYSIS; HUMANS; IONS; MALE; MICROSCOPY, ELECTRON, SCANNING; NEUROPEPTIDES; PROSTATIC NEOPLASMS;

EID: 3042823415     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Abraham E.H., Breslow J.L., Epstein J., Chang-Sing P. and Lechene C. (1985). Preparation of individual human diploid fibroblasts and study of ion transport. Am. J. Physiol. 248, C154-164.
2. Abrahamsson P.A. (1999). Neuroendocrine differentiation in prostatic carcinoma. Prostate 39, 135-148.
3. Allard P., Beaulieu P., Aprikian A. and Chevalier S. (2000). Bombesin modulates the association of Src with a nuclear 110-kd protein expressed in dividing prostate cells. J. Androl. 21, 367-375.
4. Barbiero G., Duranti F., Bonelli G., Amenta J.S. and Baccino F.M. (1995). Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp.Cell Res. 217, 410-418.
5. Barros L.F., Hermosilla T. and Castro J. (2001). Necrotic volume increase and the early physiology of necrosis. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 30, 401-409.
6. Berger R. and Garnier Y. (1999). Pathophysiology of perinatal brain damage. Brain Res. Rev. 30, 107-134.
7. Bologna M., Festuccia C., Muzi P., Biordi L. and Ciomei M. (1989). Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63, 1714-1720.
8. + efflux in the activation of apoptosis. J. Biol. Chem. 272, 32436-32442.
9. Bowen I.D., Worrill N.A., Winters C.A. and Mullarkey K. (1988). The use of backscattered electron imaging, X ray microanalysis and X-ray microscopy in demonstrating physiological cell death. Scan. Microsc. 2, 1453-1462.
10. Chien J., Ren, Y., Quin, W.Y., Bordelon, W., Thompson, E., Davis, R., Rayford W. and Shah G. (2001). Calcitonin is a prostate-epithelium-derived growth stimulator peptide. Mol. Cell. Endocrinol. 181, 69-79.
11. Cox M.E., Deeble P.D., Lakhnai S. and Parsons S.J. (1999). Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res. 59, 3821-3838
12. Craft N., Chhor C., Tran C., Belldegrun A., De Kernion J., Witte O.N., Said J., Reiter R.E. and Sawyers C.L. (1999). Evidence for clonal outgrowth of androgen independent prostate cancer cells from androgen-dependent tumors trough a two-step process. Cancer Res. 59, 5030-5036.
13. Dallaporta B., Hirsch T., Susin SA., Zamzami N., Larochette N., Brenner C., Marzo I. and Kroemer G. (1998). Potassium leakage during the apoptotic degradation phase. J. Immunol. 160, 5605-5615.
14. Dallaporta B., Marchetti P., de Pablo M.A., Maisse C., Duc H.T., Metivier D., Zamzami N., Geuskens M. and Kroemer G. (1999). Plasma membrane potential in thymocyte apoptosis. J. Immunol. 162, 6534-6542.
15. di Sant'Agnese P.A. (1998). Neuroendocrine differentiation in prostatic carcinoma: an update. Prostate suppl 8, 74-79.
16. Fernandez-Segura E., Cañizares F.J., Cubero M.A., Warley A. and Campos A. (1999). Changes in elemental content during apoptotic death studied by electron probe X-ray microanalysis. Exp. Cell Res. 253, 454-462.
17. Festuccia C., Guerra F., D'Ascenzo S., Giunciuglio D., Albini A. and Bologna M. (1998). In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer 75, 418-431.
18. + current induced by external ATP in PC12 cells. Clin. Exp. Pharmacol. Physiol. 26, 39-47.
19. Goodin J.L. and Rutherford C.L. (2002). Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP. Mol. Carcinogen. 33, 88-98.
20. Grängsjö A., Lindberg M. and Roomans G.M. (1997). Methods for x-ray microanalysis of epidermis: the effect of local anaesthesia. J. Microsc. 186, 23-27.
21. Grängsjö A., Ybo A., Roomans G.M. and Lindberg M. (2000). Irritant-induced keratinocyte proliferation evaluated with two different methods: immunohistochemistry and X-ray microanalysis. J Submicrosc. Cytol. Pathol. 32, 11-16.
22. Grundin T.G., Roomans G.M., Forslind B., Lindberg M. and Werner Y. (1985). X-ray microanalysis of psoriatic skin. J. Invest. Dermatol. 85, 378-380.
23. 2+ permeable cation channel by two different inducers of apoptosis in a human prostatic cancer cell line. J. Physiol. (London) 15, 95-107.
24. Han K., Viallet J., Chevalier S., Zheng W., Bazinet M. and Aprikian A.G. (1997). Characterization of intracellular calcium mobilization by bombesin-related neuropeptides in PC-3 human prostate cancer cells. Prostate 31, 53-60.
25. Hansson J. and Abrahamsson P.A. (2001). Neuroendocrine pathogenesis in adenocarcinoma of the prostate. Ann. Oncol.12 suppl 2, 145-152.
26. Hongpaisan J. and Roomans G.M. (1995). Use of postmortem and in vitro tissue specimens for x-ray microanalysis. J. Microsc. 180, 93-105.
27. Hoosein N.M. (1998). Neuroendocrine and immune mediators in prostate cancer progression. Front. Biosci. 3, 1274-1279.
28. + suppresses the activation of apoptosis in lymphocytes. J. Biol. Chem. 272, 30567-30676.
29. Hughes F.M. Jr and Cidlowski J.A. (1999). Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv. Enzyme Regul. 39, 157-71.
30. Ito T., Yamamoto S., Ohno Y., Namiki K., Aizawa T., Akiyama A. and Tachibana M. (2001). Up-regulation of neuroendocrine differentiation in prostate cancer after androgen deprivation therapy, degree and androgen independence. Oncol. Rep. 8, 1221-1224.
31. Ingram P., Shelburne J.D. and Le Furgey A. (1999). Principles and instrumentation. In: Biomedical applications of microprobe analysis. Ingram P., Shelburne J., Roggil V. and Le Furgey A. (eds). Academic Press. London. pp 1-58.
32. Isaacs J.T. (1999). The biology of hormone refractory prostate cancer. Why does it develop? Urol. Clin. North. Am. 26, 263-273.
33. Jongsma J., Oomen M.H., Noordzij M.A., Romijn J.C., van der Kwast T.H., Schröder F.H. and van Steenbrugge G.J. (2000). Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate 42, 34-44.
34. Jungwirth A., Pinski J., Galvan G., Halmos G., Szepeshazi K., Cai R.Z, Groot K., Vadillo-Buenfil M. and Schally A.V. (1997). Inhibition of growth of androgen-independent Du-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. Eur. J. Cancer 33, 1141-1148.
35. Kampf C., Relova A.J., Sandler S. and Roomans G.M. (1999). Effects of TNF-alpha, IFN-gamma and IL-beta on normal human bronchial epithelial cells. Eur. Resp. J. 14, 84-91.
36. Maeno E., Ishizaki Y., Kanaseki T., Hazama A. and Okada Y. (2000). Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. USA 97, 9487-9492.
37. Mason R.P. (1999). Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?. J. Am. Coll. Cardiol. 34, 1857-1866.
38. Montague J.W., Bortner C.D., Hughes F.M. Jr. and Cidlowski J.A. (1999). A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis. Steroids 64, 563-569.
39. Nilius B. (2001). Chloride channels go cell cycling J. Physiol. 532, 581.
40. + ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. J. Biol. Chem. 274, 16545-16552.
41. Ouadid-Ahidouch H., Van Coppenolle F., Le Bourhis X., Belhaj A. and Prevarskaya N. (1999). Potassium channels in rat prostate epithelial cells. FEBS Letters 459, 15-21.
42. Pilat M.J., Kamradt J.M. and Pienta K.J. (1999). Mechanisms of hormone resistance in prostate cancer. Cancer Metast. Rev. 17, 373-381.
43. Pinski J., Reile H., Halmos G., Groot K. and Schally A.V. (1994). Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Cancer Res. 54, 169-174.
44. Pinski J., Schally A.V., Halmos G. and Szepeshazi K. (1993). Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. Int. J. Cancer 55, 963-967.
45. Ritchie C.K., Thomas K.G., Andrews L.R., Tindall D.J. and Fitzpatrick L.A. (1997). Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis. Prostate 30, 183-187.
46. Roomans G.M. (1988). Quantitative x-ray microanalysis of biological specimens. J. Electr. Microsc. Tech. 9, 19-44.
47. Roomans G.M. (2002). X-ray microanalysis of epithelial cells in culture. In: Epithelial cell culture protocols. Methods in molecular biology,. Vol. 18. Wise C. (ad). Humana Press. Totowa, NJ. pp 273-289.
48. Roomans G.M., Hongpaisan J., Jin Z., MM A.C. and Zhang A. (1996). In vitro systems and cultured cells as specimens for x-ray microanalysis. Scanning Microsc. Suppl. 10, 359-370.
49. Roomans G.M., Vilches J., López A. and Salido M. (2001). Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in a prostate cancer cell line. In: Proceedings SCANDEM 2001. Stockholm: Scandinavian Society for Electron Microscopy, 2001: B427-B428.
50. Salido M., López A., Aparicio J., Larrán J. and Vilches J. (1996). Characterization of apoptosis in prostatic androgen independent cell lines. Int. J. Dev. Biol. suppl 1, 191-192.
51. Salido M., Larrán J., Vilches J., López A. and Aparicio J. (1999). Etoposide sensitivity of human prostatic cancer cell lines PC-3, Du 145, LNCaP. Histol. Histopathol. 14, 125-134.
52. Salido M., Vilches J. and Lopez A. (2000). Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines. Histol. Histopathol. 15, 729-738.
53. Salido M., Vilches J., López A. and Roomans G.M. (2001). X-ray microanalysis of etoposide induced apoptosis in the PC-3 prostatic cancer cell line. Cell Biol. Int. 25, 499-508.
54. Salido M., Vilches J., López A. and Roomans G.M. (2002). Neuropeptides bombesin and calcitonin inhibit apoptosis related elemental changes in prostate cancer cell lines. Cancer 94, 368-377.
55. Sandström P.E., Jonsson O., Grankvist K. and Henriksson R. (1994). Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines. Eur. J. Cancer 30, 1822-1826.
56. Segawa N., Mori I., Utsunomiya H., Nakamura M., Nakamura Y., Shan, L., Katudo K. and Katsuoka Y. (2001). Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer. Pathol. Int. 51, 452-459.
57. 2+ transients. Endocrinology 134, 596-602.
58. Skepper J.N., Karydis I., Garnett M.R., Hegyi L., Hardwick S.J., Warley A., Mitchinson M.J. and Cary N.R. (1999). Changes in elemental concentrations are associated with early stages of apoptosis in human monocyte-macrophages exposed to oxidized low-density lipoprotein: an X-ray microanalytical study. J. Pathol. 188, 100-106.
59. Smith N.K.R. and Cameron I.L. (1999). Ionic regulation of proliferation in normal and cancer cells. In: Biomedical applications of microprobe analysis. Ingram P., Shelburne J.D., Roggli V.L. and LeFurgey A., (eds). Academic Press. San Diego. pp 445-459.
60. Smith P., Rhodes N.P., Shortland A.P., Fraser S.P., Djamgoz M.B., Ke Y. and Foster C.S. (1998). Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett. 423, 19-24.
61. Tapia-Vieyra J.V. and Mas-Oliva J. (2001). Apoptosis and cell death channels in prostate cancer. Arch. Med. Res. 32, 175-185.
62. Von Euler A., Pålsgård E., Vult von Steyern C. and Roomans G.M. (1993). X-ray microanalysis of epithelial and secretory cells in culture. Scanning Microsc. 7, 191-202.
63. Warley A. (1997). X-Ray microanalysis for biologists. Portland Press. Cambridge.
64. Warley A., Arrebola F., Zabiti S., Cañzares F., Cubero M.A., Fernandez-Segura E. and Campos A. (2000). Changes in sodium, chloride and potassium during apoptotic cell death. An X-ray microanalytical study. In: Proc 12th Eur Congress Electron Microsc. Frank L and Ciampor F. (eds). Brno: Czechoslovak Soc Electron Microsc, 2000. B427-13428.
65. Wasilenko W.J., Cooper J., Palad A.J., Somers K.D., Blackmore P.F., Rhim J.S., Wright G.L. Jr, Schellhammer P.F. (1997). Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate 30, 167-173.
66. Yu D.S., Hsieh D.S., Chen H.I. and Chang S.Y. (2001). The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications. J. Urol. 166, 871-875.
67. Yu S.P. and Choi D.W. (2000). Ions, cell volume and apoptosis. Proc. Natl. Acad. Sci. USA 97, 9360-9362.
68. Zelivianski S., Verni M., Moore C., Kondrikov D., Taylor R. and Lin M.F. (2001). Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Biochim. Biophys. Acta 1539, 28-43.